Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Hormone Replacement Therapy Market: By Product: Oestrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Others; By Route of Administration; By Type of Disease; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Hormone Replacement Therapy Market Outlook
The global hormone replacement therapy market attained a value of USD 4.5 billion in 2020 and is projected to reach USD 6.7 billion by 2026, growing at a CAGR of 6.9% over the forecast period of 2021-2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the product type, the oestrogen replacement therapy segment held the majority of the market share in 2020. Based on the route of administration, the parenteral segment is estimated to be the leading segment, accounting for the majority of the market share, followed by oral and transdermal methods.
Regionally, the market is segmented into North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America was the largest market in 2020, accounting for the majority of the market share.
Properties and Applications
Hormone replacement therapy (HRT) is a treatment used for replenishing the hormones which are present in low levels in the human body. This therapy is particularly favourable for the patients having a deficiency of growth hormone, women in menopausal transition, and geriatric suffering from hypogonadism. It is available in several forms, such as gels, skin, and mouth patches (transdermal), injections, and implants. It is also considered to be a more efficient treatment in comparison to its alternatives, such as chemical drugs, herbal medicines, and others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major product types of the market are:
- Oestrogen Replacement Therapy
- Human Growth Hormone Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
- Others
On the basis of route of administration, the industry can be segmented into:
- Oral
- Parenteral
- Transdermal
Based on the type of diseases, the market is divided into:
- Menopause
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Others
The EMR report looks into the regional markets like North America, the Asia Pacific, Europe, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
A rise in the incidences of hormonal imbalance disorders in the neonatal and geriatric populations is primarily driving the market growth. HRT is effective for the treatment of the symptoms of menopause such as night sweats, hot flashes, vaginal dryness, and sexual function. Additionally, it minimises the risk of cardiovascular diseases, vasomotor symptoms, colorectal cancer, and osteoporosis while improving the quality of life. Furthermore, advancements in technology such as the introduction of transdermal drug delivery and new gel-based formulations, coupled with increased investments in research and development activities by the manufacturers are providing a boost to the market growth. Moreover, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations are further expected to stimulate the demand for hormone replacement therapy during the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global hormone replacement therapy market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott
- Novo Nordisk A/S
- Pfizer Inc
- Allergan
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Route of Administration, Type of Disease, Region |
| Breakup by Product | Oestrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, Others |
| Breakup by Route of Administration | Oral, Parenteral, Transdermal |
| Breakup by Type of Disease | Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott, Novo Nordisk A/S, Pfizer Inc, Allergan, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Hormone Replacement Therapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Hormone Replacement Therapy Historical Market (2016-2020)
8.3 Global Hormone Replacement Therapy Market Forecast (2021-2026)
8.4 Global Hormone Replacement Therapy Market by Product
8.4.1 Oestrogen Replacement Therapy
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 Human Growth Hormone Replacement Therapy
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Thyroid Replacement Therapy
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Testosterone Replacement Therapy
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.4.5 Others
8.5 Global Hormone Replacement Therapy Market by Route of Administration
8.5.1 Oral
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.2 Parenteral
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.3 Transdermal
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2016-2020)
8.5.3.3 Forecast Trend (2021-2026)
8.6 Global Hormone Replacement Therapy Market by Type of Disease
8.6.1 Menopause
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Hypothyroidism
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Male Hypogonadism
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Growth Hormone Deficiency
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2016-2020)
8.6.4.3 Forecast Trend (2021-2026)
8.6.5 Others
8.7 Global Hormone Replacement Therapy Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Company Profiles
12.3.1 Abbott
12.3.1.1 Company Overview
12.3.1.2 Product Portfolio
12.3.1.3 Demographic Reach and Achievements
12.3.1.4 Certifications
12.3.2 Novo Nordisk A/S
12.3.2.1 Company Overview
12.3.2.2 Product Portfolio
12.3.2.3 Demographic Reach and Achievements
12.3.2.4 Certifications
12.3.3 Pfizer Inc
12.3.3.1 Company Overview
12.3.3.2 Product Portfolio
12.3.3.3 Demographic Reach and Achievements
12.3.3.4 Certifications
12.3.4 Allergan
12.3.4.1 Company Overview
12.3.4.2 Product Portfolio
12.3.4.3 Demographic Reach and Achievements
12.3.4.4 Certifications
12.3.5 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Hormone Replacement Therapy Market: Key Industry Highlights, 2016 and 2026
2. Global Hormone Replacement Therapy Historical Market: Breakup by Product (USD Billion), 2016-2020
3. Global Hormone Replacement Therapy Market Forecast: Breakup by Product (USD Billion), 2021-2026
4. Global Hormone Replacement Therapy Historical Market: Breakup by Route of Administration (USD Billion), 2016-2020
5. Global Hormone Replacement Therapy Market Forecast: Breakup by Route of Administration (USD Billion), 2021-2026
6. Global Hormone Replacement Therapy Historical Market: Breakup by Type of Disease (USD Billion), 2016-2020
7. Global Hormone Replacement Therapy Market Forecast: Breakup by Type of Disease (USD Billion), 2021-2026
8. Global Hormone Replacement Therapy Historical Market: Breakup by Region (USD Billion), 2016-2020
9. Global Hormone Replacement Therapy Market Forecast: Breakup by Region (USD Billion), 2021-2026
10. North America Hormone Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2016-2020
11. North America Hormone Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Europe Hormone Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Europe Hormone Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Asia Pacific Hormone Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Asia Pacific Hormone Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Latin America Hormone Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Latin America Hormone Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Middle East and Africa Hormone Replacement Therapy Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Middle East and Africa Hormone Replacement Therapy Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Global Hormone Replacement Therapy Market Structure
Key Questions Answered in the Report
In 2020, the global hormone replacement therapy market attained a value of nearly USD 4.5 billion.
The market is projected to grow at a CAGR of 6.9% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 6.7 billion by 2026.
The major drivers of the industry, such as rise in the incidences of hormonal imbalance disorders, increasing awareness among the consumers, ageing population, sedentary lifestyles, and the presence of regularly monitored formulations, are expected to aid the market growth.
The key market trend guiding the growth of the hormone replacement therapy market includes the introduction of transdermal drug delivery and new gel-based formulations.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest market share.
The oestrogen replacement therapy segment is the leading product in the industry.
The route of administration is led by parenteral segment in the industry.
The significant types of diseases in the industry are menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency, among others.
The major players in the industry are Abbott, Novo Nordisk A/S, Pfizer Inc, and Allergan, among others.
Analyst Review
The global hormone replacement therapy market attained a value of USD 4.5 billion in 2020, driven by the increasing awareness among the consumers. Aided by technological advancements, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 6.9%. The market is projected to reach USD 6.7 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product type, the oestrogen replacement therapy segment is the dominant product in the industry. On the basis of route of administration, the parenteral segment is the leading segment. On the basis of type of disease, the industry is divided into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and others. The major regional markets for hormone replacement therapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the industry. The key players in the above industry include Abbott, Novo Nordisk A/S, Pfizer Inc, Allergan, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global neutropenia treatment market attained a value of about USD 13.4 billion in 2020, driven by the rise in cancer cases leading to development of novel therapies. Aided by the rising awareness ...
The United States vaccine market attained a value of nearly USD 11.2 billion in 2020, driven by the rising use of mRNA technology in vaccine development. Aided by advancements in biotechnology and gen...
The global immunomodulators market attained an approximate value of USD 175 billion in 2020, driven by the rising prevalence of awareness among the masses regarding immunomodulators. Aided by the risi...
The global telmisartan market attained a value of about USD 3,574 million in 2020, driven by the rising cases of hypertension and cardiovascular diseases. Aided by the robustly growing pharmaceutical ...
The global doxorubicin market attained a value of about USD 1,075.90 million in 2020, driven by the rising cases of cancer worldwide. Aided by government investments in the pharmaceutical sector, the ...
NEWSLETTER